Survey of Antimicrobial Resistance in Clinical Burkholderia pseudomallei Isolates over Two Decades in Northeast Thailand-Reference-Cited by-同舟云学术

Survey of Antimicrobial Resistance in Clinical Burkholderia pseudomallei Isolates over Two Decades in Northeast Thailand

Published:2011-11 Issue:11 Volume:55 Page:5388-5391
ISSN:0066-4804
Container-title:Antimicrobial Agents and Chemotherapy
language:en
Short-container-title:Antimicrob Agents Chemother

Author:

Wuthiekanun Vanaporn¹,Amornchai Premjit¹,Saiprom Natnaree²,Chantratita Narisara¹²,Chierakul Wirongrong¹³,Koh Gavin C. K. W.¹⁴,Chaowagul Wipada⁵,Day Nicholas P. J.¹⁶,Limmathurotsakul Direk¹⁷,Peacock Sharon J.¹²⁴

Affiliation:

1. Mahidol-Oxford Tropical Medicine Research Unit, Mahidol University, Bangkok, Thailand

2. Department of Microbiology and Immunology, Mahidol University, Bangkok, Thailand

3. Department of Clinical Tropical Medicine, Mahidol University, Bangkok, Thailand

4. Department of Medicine, Cambridge University, Addenbrooke's Hospital, Cambridge, United Kingdom

5. Department of Medicine, Sappasithiprasong Hospital, Ubon Ratchathani, Thailand

6. Centre for Clinical Vaccinology and Tropical Medicine, Nuffield Department of Clinical Medicine, University of Oxford, Churchill Hospital, Oxford, United Kingdom

7. Department of Tropical Hygiene, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand

Abstract

ABSTRACT A 21-year survey conducted in northeast Thailand of antimicrobial resistance to parenteral antimicrobial drugs used to treat melioidosis identified 24/4,021 (0.6%) patients with one or more isolates resistant to ceftazidime ( n = 8), amoxicillin-clavulanic acid ( n = 4), or both drugs ( n = 12). Two cases were identified at admission, and the remainder were detected a median of 15 days after starting antimicrobial therapy. Resistance to carbapenem drugs was not detected. These findings support the current prescribing recommendations for melioidosis.

Publisher

American Society for Microbiology

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology

Link

https://journals.asm.org/doi/pdf/10.1128/AAC.05517-11

Reference23 articles.

1. Oral fluoroquinolones for maintenance treatment of melioidosis

2. A Randomized Controlled Trial of Granulocyte Colony-Stimulating Factor for the Treatment of Severe Sepsis Due to Melioidosis in Thailand

3. Maintenance therapy of melioidosis with ciprofloxacin plus azithromycin compared with cotrimoxazole plus doxycycline.

4. Two Randomized Controlled Trials of Ceftazidime Alone versus Ceftazidime in Combination with Trimethoprim-Sulfamethoxazole for the Treatment of Severe Melioidosis

5. Clinical and Laboratory Standards Institute. 2010. Performance standards for antimicrobial susceptibility testing; twentieth informational supplement. M100-S20 vol. 30(1) p. 40-53. Clinical and Laboratory Standards Institute Wayne PA.

Cited by 78 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multi-locus sequence typing and genetic diversity of antibiotic-resistant genes and virulence-associated genes in Burkholderia pseudomallei: Insights from whole genome sequencing of animal and environmental isolates in Thailand;Veterinary Microbiology;2024-11

2. Shared challenges to the control of complex intracellular neglected pathogens;Frontiers in Public Health;2024-09-11

3. Subtractive proteomics-guided vaccine targets identification and designing of multi-epitopes vaccine for immune response instigation against Burkholderia pseudomallei;International Journal of Biological Macromolecules;2024-06

4. The Rapid Emergence of Hypervirulent Klebsiella Species and Burkholderia pseudomallei as Major Health Threats in Southeast Asia: The Urgent Need for Recognition as Neglected Tropical Diseases;Tropical Medicine and Infectious Disease;2024-04-08

5. Identification of Burkholderia cepacia strains that express a Burkholderia pseudomallei -like capsular polysaccharide;Microbiology Spectrum;2024-03-05